Macrophage activation syndrome: A rare complication of incomplete Kawasaki disease

Annals of Tropical Paediatrics

Volumn 30, Issue 1, 2010, Pages 61-64

  Suresh, N ^a   Sankar, J ^a  

^a KANCHI KAMAKOTI CHILDS TRUST HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CEFTRIAXONE; DOUBLE STRANDED DNA; FERRITIN; FIBRINOGEN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; RHEUMATOID FACTOR; TRIACYLGLYCEROL;

ABNORMAL LABORATORY RESULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHILD; CORONARY ARTERY DILATATION; DRUG DOSE REDUCTION; ECHOGRAPHY; ELBOW DISEASE; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HEPATOSPLENOMEGALY; HUMAN; LEG DISEASE; MACROPHAGE ACTIVATION SYNDROME; MORNING DOSAGE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PALLOR; PANCYTOPENIA; POLYARTHRITIS; PRESCHOOL CHILD; TREATMENT DURATION; WRIST DISEASE;

CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MACROPHAGE ACTIVATION SYNDROME; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 77749280553     PISSN: 02724936     EISSN: 14653281     Source Type: Journal    
DOI: 10.1179/146532810X12637745452239     Document Type: Article

References (11)

1. Tristano AG. Macrophage activation syndrome: a frequent but underdiagnosed complication associated with rheumatic diseases. Med Sci Monit 2008;14:R27-36.
2. Muise A, Tallett SE, Silverman ED. Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome? Pediatrics 2003;112:495.
3. Suresh N, Varadarajan VV, Ranjith MS. Kawasaki disease in south india: a prospective, case-control study. Ann Trop Paediatr 2007;27:277-83.
4. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 1985;106:561-6.
5. Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993;11:451-6.
6. Gromm AA, Passo M. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr 1996;129:750-4.
7. You CR, Kim HR, Yoon CH, Lee SH, Park SH, Kim HY. Macrophage activation syndrome in juvenile rheumatoid arthritis successfully treated with cyclosporine A: a case report. J Korean Med Sci 2006;21:1124-7.
8. Stephan JL, Kone-Paut i, Galambrun C. Reactive haemophagocytic syndrome in children with inflammatory disorders: a retrospective study of 24 patients. Rheumatology 2001;40:1285-92.
9. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.
10. Kelly A, Ramanan AV. A case of macrophage activation syndrome successfully treated with ana-kinra. Nat Clin Pract Rheumatol 2008;4:615-20.
11. Cummings C, McCarthy P, van Hoff J, et al. Kawasaki disease associated with reactive hemo-phagocytic lymphohistiocytosis. Pediatr infect Dis J 2008;27:1116-18.